These data provide additional support for the anti-obesity actions of IL6 [21, 75] and suggests that enhanced capacity to produce IL6 in the hypothalamus could be a genetically determined mechanism that protects against excessive body mass gain. The gene discussed is IL6; the disease is obesity due to melanocortin 4 receptor deficiency.